Digital Biomarkers: Global Markets

Digital Biomarkers: Global Markets

Report Scope:

The current report highlights the current and future market potential of digital biomarkers and also covers market projections to 2026, along with rankings for key market players. It also analyzes the competitive landscape and the regulatory scenario. The report determines the market share of digital biomarkers based on system components, application, therapeutic area and end user. The market by system component is segmented into data collection tools and data integration tools; by application, it is segmented into diagnostic digital biomarkers, monitoring digital biomarkers, predictive digital biomarkers and others; by therapeutic area, it is categorized into cardiovascular and metabolic disorders (CVMD), psychiatric disorders, neurological disorders, respiratory disorders, musculoskeletal disorders and others; and by end user, it is segmented into pharmaceutical companies and research institutions, healthcare providers, payers, employers, patients and caregivers. The report also assesses the impact of the COVID-19 pandemic on this market.

By geography, the market has been segmented into North America, Europe, Asia-Pacific and the rest of the world (RoW). North America consists of the U.S., Canada and Mexico; Europe includes Germany, the U.K., Belgium and Rest of Europe; and Asia-Pacific includes China, Australia, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the historic year, 2020 as the base year and forecast for 2026.

Report Includes:

- 56 tables
- An overview of the global markets for digital biomarkers
- Estimation of the market size and analyses of market trends, with data from 2019, 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Information on major market drivers, opportunities and challenges, industry chain structure, distribution channel, and technological advancements that are affecting the overall marketplace
- Assessment of market potential and revenue forecast for digital biomarkers market based on system component, application, therapeutic area, end user and region
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Company profiles of the leading market players including AliveCor, Biogen Inc., Embic Corp., Fitbit, Happify Health, Mindstrong Health, and Winterlight Labs

Companies Mentioned

ACTIGRAPH LLC
AKILI INTERACTIVE LABS INC.
ALIVECOR INC.
BIOGEN INC.
EMBIC CORP.
EVIDATION HEALTH INC.
FITBIT LLC
HAPPIFY HEALTH
HUMA
IXICO PLC
KONEKSA
MINDSTRONG HEALTH
WINTERLIGHT LABS